The Latest News on Treatment and Research for Myeloproliferative Neoplasms (MPNs)

SEATTLE - Sept. 18, 2015 - PRLog -- Innovations in the field of myeloproliferative neoplasms (MPNs) are expanding research and increasing the understanding of MPNs. These advances are making a difference and improving the lives of those living with polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF). On Saturday, October 3, in Seattle, WA, Patient Power and its partner, the Seattle Cancer Care Alliance (SCCA), will conduct a town meeting, where you will hear the latest research and treatment news from renowned MPN experts.

During this interactive event, you will have the opportunity to meet and connect with other patients and care partners living with MPNs. Your feedback during the event will help shape the conversation. Our hope is that you’ll share your knowledge among your peers to learn and be inspired by those you meet.

Please join us in person for this FREE interactive event to learn:

How to better understand MPNs and how they are treated
The latest research and clinical trials
Approaches to effectively communicate with your healthcare team and to partner in your treatment decisions
Strategies for monitoring your condition and for managing side effects
Advice and tips for living well with an MPN


Our expert panel will take your questions throughout the program. Local advocacy groups will also be on hand to offer support and to help you connect with the MPN community. Featured speakers include Bart Scott, MD (Seattle Cancer Care Alliance), Jamile M. Shammo, MD, FASCP, FACP (Rush University Medical Center), Emily Stevens, MD, PhD (Fred Hutchinson Cancer Research Center at the University of Washington), Barbara Rodgers, RN, BSN, OCN (Seattle Cancer Care Alliance).